For the most part, most insurances are accepted. KDKA-TV asked Point Park University Professor Dr. Archish Maharaja about ...

(Reuters) - The Texas attorney general has sued leading insulin manufacturers and pharmacy benefit managers (PBMs), accusing ...

Texas Attorney General Ken Paxton has filed a lawsuit against several major insulin manufacturers and pharmacy benefit ...

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

In 2023, about 80% of all prescription drug claims in the U.S. were processed by only three companies. VC-backed Rightway CEO ...

The FDA approved a new strength of a trastuzumab biosimilar; UnitedHealth will remove reference adalimumab from some ...

UPMC said wants to make access to care outside of the emergency room more convenient and less costly, especially for ...

Number 3: Part 2 of our series diving into the Association for Accessible Medicines' (AAM) latest report discusses that while generics and biosimilars saved $445 billion in 2023, their potential is ...

The state of Texas is accusing major pharmacy benefit managers and drug companies of colluding to raise the cost of insulin.

ManipalCigna Health Insurance has launched its new Sarvah health insurance plans, aiming to provide affordable and inclusive coverage for Bhar.

House Bill 596 aims to protect patients and pharmacies, by forcing pharmacy benefit managers to be more transparent with ...

UnitedHealth Group and Centene's Ambetter are expanding sales of individual coverage under the Affordable Care Act into ...